Table 1.
Clinical characteristics of the sample (N = 220).
| N | % | ||
|---|---|---|---|
| Type of cancer | Breast | 163 | 74.1% |
| Lymphoma | 7 | 3.2% | |
| Colorectal | 6 | 2.7% | |
| Lung | 5 | 2.3% | |
| Kidney | 3 | 1.4% | |
| Stomach | 2 | 0.9% | |
| Uterus | 2 | 0.9% | |
| Leukemia | 1 | 0.5% | |
| Melanoma | 1 | 0.5% | |
| Pancreas | 1 | 0.5% | |
| Prostate | 1 | 0.5% | |
| Bladder | 1 | 0.5% | |
| Sarcoma | 1 | 0.5% | |
| Other | 26 | 11.8% | |
| Disease stage | I | 23 | 10.5% |
| II | 43 | 19.5% | |
| III | 76 | 34.5% | |
| IV | 49 | 22.3% | |
| Unknown to the participant | 29 | 13.2% | |
| Disease phase | Diagnosis | 2 | 0.9% |
| Relapse | 13 | 5.9% | |
| Remission | 128 | 58.2% | |
| Treatment | 77 | 35% | |
| Time in months since diagnosis | ≤12 | 35 | 15.9% |
| >12 e ≤24 | 43 | 19.5% | |
| >24 e ≤36 | 39 | 17.7% | |
| >34 e ≤48 | 23 | 10.5% | |
| >46 e ≤60 | 22 | 9.6% | |
| >60 | 78 | 26.8% |